{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:25:12Z","timestamp":1776893112209,"version":"3.51.2"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbi.2020.05.035","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:02:36Z","timestamp":1589806956000},"page":"781-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Central IRAK-4 kinase inhibition for the treatment of pain following nerve injury in rats"],"prefix":"10.1016","volume":"88","author":[{"given":"Katrien","family":"Pletinckx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duygu","family":"Krings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Welbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten R.","family":"Dunkern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2020.05.035_b0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ni.3028","article-title":"A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4","volume":"15","author":"Alsina","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0010","doi-asserted-by":"crossref","first-page":"14062","DOI":"10.1523\/JNEUROSCI.3795-08.2008","article-title":"Nociceptors are interleukin-1beta sensors","volume":"28","author":"Binshtok","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2020.05.035_b0015","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0041-0101(98)00158-5","article-title":"Pharmacotherapeutic potential of omega-conotoxin MVIIA (SNX-111), an N-type neuronal calcium channel blocker found in the venom of Conus magus","volume":"36","author":"Bowersox","year":"1998","journal-title":"Toxicon : official journal of the International Society on Toxinology"},{"key":"10.1016\/j.bbi.2020.05.035_b0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.bbi.2020.05.035_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-8118-9-3","article-title":"Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months","volume":"9","author":"Chiu","year":"2012","journal-title":"Fluids and barriers of the CNS"},{"key":"10.1016\/j.bbi.2020.05.035_b0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.immuni.2010.08.012","article-title":"Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors","volume":"33","author":"Cros","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2020.05.035_b0035","doi-asserted-by":"crossref","first-page":"10865","DOI":"10.1074\/jbc.M113.544809","article-title":"Interleukin 1\/Toll-like receptor-induced autophosphorylation activates interleukin 1 receptor-associated kinase 4 and controls cytokine induction in a cell type-specific manner","volume":"289","author":"Cushing","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2020.05.035_b0040","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13075-019-2008-6","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjects","volume":"21","author":"Danto","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.bbi.2020.05.035_b0045","doi-asserted-by":"crossref","first-page":"15195","DOI":"10.1074\/jbc.RA118.003314","article-title":"Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling","volume":"293","author":"De Nardo","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2020.05.035_b0050","doi-asserted-by":"crossref","first-page":"15208","DOI":"10.1074\/jbc.RA118.003831","article-title":"Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling","volume":"293","author":"De","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2020.05.035_b0055","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/mp.2015.174","article-title":"Brain-borne IL-1 adjusts glucoregulation and provides fuel support to astrocytes and neurons in an autocrine\/paracrine manner","volume":"21","author":"Del Rey","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2020.05.035_b0060","doi-asserted-by":"crossref","first-page":"E514","DOI":"10.1073\/pnas.1620139114","article-title":"Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts","volume":"114","author":"Della Mina","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.bbi.2020.05.035_b0065","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4049\/jimmunol.1600583","article-title":"Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity","volume":"198","author":"Dudhgaonkar","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.26529","article-title":"Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers","volume":"31","author":"Dzamko","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2020.05.035_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1042\/CBI20100247","article-title":"Interleukin-1beta-induced interleukin-6 production in A549 cells is mediated by both phosphatidylinositol 3-kinase and interleukin-1 receptor-associated kinase-4","volume":"35","author":"Eda","year":"2011","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.bbi.2020.05.035_b0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/bja\/aet128","article-title":"Neuroinflammation and the generation of neuropathic pain","volume":"111","author":"Ellis","year":"2013","journal-title":"Br J. Anaesth."},{"key":"10.1016\/j.bbi.2020.05.035_b0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.bbi.2020.05.035_b0090","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3621","article-title":"Pathological pain and the neuroimmune interface","volume":"14","author":"Grace","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1744-8069-4-63","article-title":"Long-term actions of interleukin-1beta on delay and tonic firing neurons in rat superficial dorsal horn and their relevance to central sensitization","volume":"4","author":"Gustafson-Vickers","year":"2008","journal-title":"Mol Pain"},{"key":"10.1016\/j.bbi.2020.05.035_b0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2008.06321.x","article-title":"Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)","volume":"28","author":"Hutchinson","year":"2008","journal-title":"The European journal of neuroscience"},{"key":"10.1016\/j.bbi.2020.05.035_b0105","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.bbi.2020.05.035_b0110","doi-asserted-by":"crossref","first-page":"9347696","DOI":"10.1155\/2018\/9347696","article-title":"Koumine Attenuates Neuroglia Activation and Inflammatory Response to Neuropathic Pain","volume":"2018","author":"Jin","year":"2018","journal-title":"Neural Plast"},{"key":"10.1016\/j.bbi.2020.05.035_b0115","doi-asserted-by":"crossref","first-page":"5238730","DOI":"10.1155\/2016\/5238730","article-title":"Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model","volume":"2016","author":"Jurga","year":"2016","journal-title":"Neural. Plast."},{"key":"10.1016\/j.bbi.2020.05.035_b0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejphar.2016.06.039","article-title":"Pattern recognition receptors in chronic pain: Mechanisms and therapeutic implications","volume":"788","author":"Kato","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbi.2020.05.035_b0125","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.20061523","article-title":"Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling","volume":"204","author":"Kawagoe","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2020.05.035_b0130","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1084\/jem.20151074","article-title":"Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy","volume":"212","author":"Kelly","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2020.05.035_b0135","article-title":"Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2020.05.035_b0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20061825","article-title":"A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity","volume":"204","author":"Kim","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2020.05.035_b0145","first-page":"63","article-title":"Solving the IRAK-4 enigma: application of kinase-dead knock-in mice","author":"Koziczak-Holbro","year":"2007","journal-title":"Ernst Schering Foundation symposium proceedings"},{"key":"10.1016\/j.bbi.2020.05.035_b0150","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1172\/JCI87532","article-title":"Pericyte MyD88 and IRAK4 control inflammatory and fibrotic responses to tissue injury","volume":"127","author":"Leaf","year":"2017","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bbi.2020.05.035_b0155","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1021\/acs.jmedchem.7b00231","volume":"60","author":"Lee","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbi.2020.05.035_b0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12974-017-0822-9","article-title":"Suppression of MyD88-dependent signaling alleviates neuropathic pain induced by peripheral nerve injury in the rat","volume":"14","author":"Liu","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2020.05.035_b0165","doi-asserted-by":"crossref","first-page":"28188","DOI":"10.1038\/srep28188","article-title":"TLR signaling adaptor protein MyD88 in primary sensory neurons contributes to persistent inflammatory and neuropathic pain and neuroinflammation","volume":"6","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2020.05.035_b0170","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/eji.200737429","article-title":"IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses","volume":"38","author":"Lye","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0175","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1021\/acsmedchemlett.5b00106","article-title":"Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation","volume":"6","author":"McElroy","year":"2015","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbi.2020.05.035_b0180","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1056-8719(94)90087-6","article-title":"A method to perform direct transcutaneous intrathecal injection in rats","volume":"32","author":"Mestre","year":"1994","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bbi.2020.05.035_b0185","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.pain.2008.02.015","article-title":"Interleukin-1 alpha has antiallodynic and antihyperalgesic activities in a rat neuropathic pain model","volume":"138","author":"Mika","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2020.05.035_b0190","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S1359-6446(03)02832-0","article-title":"Solid-state analysis of the active pharmaceutical ingredient in drug products","volume":"8","author":"Newman","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bbi.2020.05.035_b0195","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.expneurol.2011.09.038","article-title":"Toll-like receptors in chronic pain","volume":"234","author":"Nicotra","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbi.2020.05.035_b0200","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/brain\/awz063","article-title":"Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons","volume":"142","author":"North","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2020.05.035_b0205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1021\/acsmedchemlett.9b00219","article-title":"Targeting IRAK4 for Degradation with PROTACs","volume":"10","author":"Nunes","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbi.2020.05.035_b0210","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.1203268","article-title":"Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice","volume":"191","author":"Pauls","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0215","doi-asserted-by":"crossref","unstructured":"Peng, J., N. Gu, L. Zhou, B.E. U, M. Murugan, W.B. Gan, and L.J. Wu. 2016. Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury. Nat Commun 7:12029.","DOI":"10.1038\/ncomms12029"},{"key":"10.1016\/j.bbi.2020.05.035_b0220","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbi.2019.09.013","article-title":"Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain","volume":"82","author":"Peng","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2020.05.035_b0225","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","article-title":"Pyogenic bacterial infections in humans with IRAK-4 deficiency","volume":"299","author":"Picard","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbi.2020.05.035_b0230","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mcn.2015.12.013","article-title":"Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine","volume":"71","author":"Pilat","year":"2016","journal-title":"Mol. Cell Neurosci."},{"key":"10.1016\/j.bbi.2020.05.035_b0235","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejphar.2015.05.058","article-title":"IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model","volume":"764","author":"Pilat","year":"2015","journal-title":"Eur. J.. Pharmacol."},{"key":"10.1016\/j.bbi.2020.05.035_b0240","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.482","article-title":"Inhibiting the immunoproteasome's beta5i catalytic activity affects human peripheral blood-derived immune cell viability","volume":"7","author":"Pletinckx","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbi.2020.05.035_b0245","doi-asserted-by":"crossref","first-page":"26748","DOI":"10.1074\/jbc.M400785200","article-title":"IRAK4 kinase activity is redundant for interleukin-1 (IL-1) receptor-associated kinase phosphorylation and IL-1 responsiveness","volume":"279","author":"Qin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2020.05.035_b0250","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainresrev.2008.12.020","article-title":"Role of interleukin-1beta during pain and inflammation","volume":"60","author":"Ren","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbi.2020.05.035_b0255","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/nn1992","article-title":"The neuropathic pain triad: neurons, immune cells and glia","volume":"10","author":"Scholz","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2020.05.035_b0260","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(99)00450-4","article-title":"Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy","volume":"270","author":"Sommer","year":"1999","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbi.2020.05.035_b0265","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.molimm.2008.12.012","article-title":"The kinase activities of interleukin-1 receptor associated kinase (IRAK)-1 and 4 are redundant in the control of inflammatory cytokine expression in human cells","volume":"46","author":"Song","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0270","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/jnr.23841","article-title":"Sex Differences in Pain","volume":"95","author":"Sorge","year":"2017","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbi.2020.05.035_b0275","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4049\/jimmunol.0802361","article-title":"IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease","volume":"183","author":"Staschke","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0280","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1113\/JP270905","article-title":"Increased excitability of medium-sized dorsal root ganglion neurons by prolonged interleukin-1beta exposure is K(+) channel dependent and reversible","volume":"593","author":"Stemkowski","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbi.2020.05.035_b0285","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/glia.22657","article-title":"LPS and IL-1 differentially activate mouse and human astrocytes: role of CD14","volume":"62","author":"Tarassishin","year":"2014","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2020.05.035_b0290","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/19420862.2017.1409320","article-title":"Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system","volume":"10","author":"Thom","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.bbi.2020.05.035_b0295","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1016\/j.bmcl.2014.03.056","article-title":"Identification and optimization of indolo[2,3-c]quinoline inhibitors of IRAK4","volume":"24","author":"Tumey","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbi.2020.05.035_b0300","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/jpet.107.126052","article-title":"(-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol hydrochloride (tapentadol HCl): a novel mu-opioid receptor agonist\/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties","volume":"323","author":"Tzschentke","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2020.05.035_b0305","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1042\/BCJ20170097","article-title":"The mechanism of activation of IRAK1 and IRAK4 by interleukin-1 and Toll-like receptor agonists","volume":"474","author":"Vollmer","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbi.2020.05.035_b0310","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1002\/eji.201242683","article-title":"Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans","volume":"42","author":"von Bernuth","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0315","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","article-title":"The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia","volume":"30","author":"Watkins","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbi.2020.05.035_b0320","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/j.pain.0000000000000810","article-title":"Enhanced delivery of IL-1 receptor antagonist to the central nervous system as a novel anti-transferrin receptor-IL-1RA fusion reverses neuropathic mechanical hypersensitivity","volume":"158","author":"Webster","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.bbi.2020.05.035_b0325","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1002\/jps.22604","article-title":"Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting","volume":"100","author":"Westerhout","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bbi.2020.05.035_b0330","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/nm.2230","article-title":"Overcoming obstacles to developing new analgesics","volume":"16","author":"Woolf","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2020.05.035_b0335","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbi.2020.05.035_b0340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0006-8993(98)00306-0","article-title":"Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat","volume":"794","author":"Yamamoto","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2020.05.035_b0345","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s11064-019-02767-8","article-title":"Interleukin-1 Receptor Associated Kinase 1 Mediates the Maintenance of Neuropathic Pain after Chronic Constriction Injury in Rats","volume":"44","author":"Yin","year":"2019","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbi.2020.05.035_b0350","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.4049\/jimmunol.1801627","article-title":"Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4-MyD88 Complex","volume":"202","author":"Zaro","year":"2019","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2020.05.035_b0355","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1096\/fj.14-267146","article-title":"Spinal cord oligodendrocyte-derived alarmin IL-33 mediates neuropathic pain","volume":"30","author":"Zarpelon","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2020.05.035_b0360","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1523\/JNEUROSCI.3681-13.2014","article-title":"Peripheral role of cathepsin S in Th1 cell-dependent transition of nerve injury-induced acute pain to a chronic pain state","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2020.05.035_b0365","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1172\/JCI65364","article-title":"WNT signaling underlies the pathogenesis of neuropathic pain in rodents","volume":"123","author":"Zhang","year":"2013","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.bbi.2020.05.035_b0370","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120301872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159120301872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:07:08Z","timestamp":1760170028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159120301872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":74,"alternative-id":["S0889159120301872"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2020.05.035","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central IRAK-4 kinase inhibition for the treatment of pain following nerve injury in rats","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2020.05.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}